Concepedia

Dongan Yu

DY

Statistics

Publications

4

Citations

119

H-Index

4

Active since

2006

Affiliations

Humanwell Healthcare Group (China)(Current)

Dongan Yu is an author at Humanwell Healthcare Group (China) specializing in oncology, medicine, and antibody-drug conjugate pharmacokinetics.

ORCID

Publications per year

2006–2024

4

Publications

4

Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes

Glenda Parsons, David W. Souza, Hao Wu et al. · Gene Therapy · 2006 · 44 citations

, , +13

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Wei Zhou, Peng Fang, Dongan Yu et al. · Molecular Cancer Therapeutics · 2023 · 41 citations · Full text

, , +15

A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cells

Xiaoding Tan, Peng Fang, Kaiying Li et al. · mAbs · 2023 · 20 citations · Full text

, , +17

Development and validation of bioanalytical assays for the quantification of 9MW2821, a nectin-4-targeting antibody–drug conjugate

Peng Fang, Meng You, Yuxia Cao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2024 · 14 citations · Full text

, , +17

1–4 of 4